Cambrex
Michael Rekrut has extensive experience in finance and accounting, currently serving as VP of Finance for Early Stage Development and Testing at Cambrex since January 2019, following the acquisition of Avista Pharma Solutions. Prior roles at Avista include Sr. Director and Corporate Controller. Michael has also held key financial positions at Booz Allen Hamilton as Senior Manager of Financial Analysis, SDI Technology Corporation as CFO, EMC as Controller of Apex Operations, and McQuay International as a Senior Financial Analyst. Michael earned an MBA in Technology Management and a BBA in Accounting from James Madison University.
This person is not in any teams
This person is not in any offices
Cambrex
4 followers
Cambrex is a global leading CDMO specializing in small molecule APIs, advanced intermediates, custom development and manufacturing and controlled substance.